Kymera’s programme focuses on removing CDK2 from cells compared to other therapies that target the protein’s inhibition.

Scientific experts are concerned about what role vaccines will play in US public health strategy under the Trump ...

The evolving landscape of vaccine oversight makes it key to maintain public trust and keep scientific integrity at the ...

Experts at HLTH Europe discussed how to ensure patients have trust in the EHDS to ensure a successful roll-out.

The US FDA has approved GSK's 200 mg/ml autoinjector of Benlysta for individuals aged five years and above with active lupus ...

Revolution Medicines has partnered Royalty Pharma for $2bn to support development and commercialisation of its RAS(ON) ...

Medera and Novoheart have collaborated with University of California San Diego School of Medicine and Mayo Clinic mini-heart ...

The FDA label update boosts GE HealthCare’s Vizamyl to a market advantage despite the emergence of blood-based tests.

Acquisitions involving innovator drugs have grown year-on-year with total deal value increasing eight-fold to almost $18 ...

The US FDA has approved Sanofi and Regeneron’s Dupixent (dupilumab) as a treatment option for adults with bullous pemphigoid.

Membrane is a winner in the Innovation, Research & Development, and Environmental categories in the 2025 Pharmaceutical ...

Novo Nordisk has ended a partnership with telehealth company Him & Hers, after launching the collaboration less than two ...